A Aralex Aachen research explorer

Ikbel Achour Sign in to save

ORCID 0000-0001-6103-4069 OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

0

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (3)

1× AstraZeneca, Gaithersburg, MD, USA
1× AstraZeneca 16 , Gaithersburg, Maryland
1× AstraZeneca, Gaithersburg, MD

Papers 3 stored

All · Aachen affiliation only

Rilvegostomig for Metastatic Non–Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study
2026 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access

1

citations
1446P Preliminary efficacy and safety of rilvegostomig (AZD2936), a bispecific antibody targeting PD-1 and TIGIT, in checkpoint inhibitor (CPI)-pretreated advanced/metastatic non-small-cell lung cancer (NSCLC): ARTEMIDE-01
2023 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

12

citations
Safety, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary efficacy of AZD2936, a bispecific antibody targeting PD-1 and TIGIT, in checkpoint inhibitor (CPI)-experienced advanced/metastatic non-small-cell lung cancer (NSCLC): First report of ARTEMIDE-01.
2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access

22

citations

3 results